Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors
- PMID: 9886435
Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors
Abstract
IL-17 is a T cell-derived cytokine that stimulates stromal cells and macrophages to secrete proinflammatory cytokines. We hypothesized that IL-17 might play a role in alloimmune responses, and that interference with its activity might suppress allograft rejection. IL-17R:Fc or control IgG was added at the start of mouse MLR or was administered i.p. (100-500 microg/day) for different durations post-transplant to murine recipients of MHC-mismatched cardiac allografts. IL-17R:Fc (50-200 microg/ml) markedly inhibited T cell proliferation in vitro and significantly prolonged nonvascularized cardiac allograft median survival time from 13 to 20 days (100 microg/day; days 0 and 1) or to 19 days (100-300 microg/day; days 0-4). Survival of vascularized grafts was also extended significantly from 10.5 to 19 days by IL-17R:Fc (500 microg/day; days 0-6). To address a possible mechanism by which IL-17 may promote alloreactivity, we examined the influence of IL-17 on the differentiation and function of bone marrow-derived cells propagated in granulocyte-macrophage CSF with or without IL-4 to promote dendritic cell (DC) growth. A minor proportion of CD11c+ DC expressed the IL-17R. IL-17 promoted the maturation of DC progenitors, as evidenced by increased cell surface expression of CD11c, costimulatory molecules (CD40, CD80, CD86), and MHC class II Ag, and allostimulatory capacity. IL-17 had a lesser effect on the phenotype and function of more fully differentiated myeloid DC. These findings suggest a role for IL-17 in allogeneic T cell proliferation that may be mediated in part via a maturation-inducing effect on DC. IL-17 appears to be a novel target for therapeutic intervention in allograft rejection.
Similar articles
-
Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.Gene Ther. 2003 Jan;10(2):143-52. doi: 10.1038/sj.gt.3301872. Gene Ther. 2003. PMID: 12571643
-
Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.Transplantation. 2003 Feb 15;75(3):407-13. doi: 10.1097/01.TP.0000044172.19087.22. Transplantation. 2003. PMID: 12589166
-
Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells.J Immunol. 1999 Jan 15;162(2):774-81. J Immunol. 1999. PMID: 9916698
-
Microchimerism, dendritic cell progenitors and transplantation tolerance.Stem Cells. 1995 Nov;13(6):622-39. doi: 10.1002/stem.5530130607. Stem Cells. 1995. PMID: 8590864 Free PMC article. Review.
-
The role of dendritic cells and T cell activation in allograft rejection.Exp Nephrol. 1993 Mar-Apr;1(2):90-101. Exp Nephrol. 1993. PMID: 8081962 Review.
Cited by
-
Strategies for local gene therapy of corneal allograft rejection.Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):11-25. doi: 10.4103/0974-9233.106382. Middle East Afr J Ophthalmol. 2013. PMID: 23580848 Free PMC article. Review.
-
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer.World J Gastroenterol. 2018 Aug 28;24(32):3583-3616. doi: 10.3748/wjg.v24.i32.3583. World J Gastroenterol. 2018. PMID: 30166856 Free PMC article. Review.
-
Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection.J Exp Med. 2008 Dec 22;205(13):3145-58. doi: 10.1084/jem.20081661. Epub 2008 Dec 15. J Exp Med. 2008. PMID: 19075290 Free PMC article.
-
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.Immunology. 2011 Sep;134(1):8-16. doi: 10.1111/j.1365-2567.2011.03465.x. Epub 2011 Jul 4. Immunology. 2011. PMID: 21726218 Free PMC article. Review.
-
Targeted deletion of Traf2 allows immunosuppression-free islet allograft survival in mice.Diabetologia. 2017 Apr;60(4):679-689. doi: 10.1007/s00125-016-4198-7. Epub 2017 Jan 6. Diabetologia. 2017. PMID: 28062921
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials